By Jared Lynch CERVICAL cancer vaccine developer Ian Frazer is hoping lightning will strike  twice with a new drug aimed at quashing another common cancer. Coridon, the company Professor Frazer founded, yesterday struck a deal  with Ohio State University to further develop its Epstein-Barr virus (EBV)  project. EBV is the cause of glandular fever and […]